Stocks To Watch Today on January 8, 2025: Kalyan Jewellers, Biocon, Paras Defence and More in Focus

On Wednesday, January 8, 2025, the Indian benchmark indices Sensex and Nifty 50 opened high from their previous closes. Sensex and Nifty 50 opened at 78,319.45 and 23,746.65, respectively. Check out a few stocks that were in focus as of 9:50 AM and might continue the same during the trading session.

• Kalyan Jewellers

Kalyan Jewellers reported its Q3 FY 2025 update on Tuesday. In the quarter ended December 31, 2024, the company saw a consolidated revenue growth of ~39% compared to the same period last year. On Wednesday, Kalyan Jewellers share price opened at ₹724.45, up from its previous close of ₹722.95. At 9:51 AM, the share price of Kalyan Jewellers was trading at ₹683.00, down by 5.53% on the NSE.

• Biocon

On Tuesday, Biocon’s subsidiary Biocon Biologics Limited celebrated its first anniversary as a fully integrated, global biosimilars company. On Wednesday, Biocon share price opened at ₹381.00, slightly down from its previous close of ₹382.35.

• Reliance Industries 

Reliance share price opened at ₹1,249.00, up from its previous close of ₹1,240.85. Recently, Mukesh Ambani’s RIL’s Reliance Consumer Products Ltd (RCPL) has launched RasKik Gluco Energy, a rehydration beverage priced at ₹10 per single-serve drink.

• Paras Defence and Space Technologies Ltd

Paras Defence has been granted a License under the Arms Act, 1959. Paras Defence share price opened at ₹1,079.80, up from its previous close of ₹1,066.10. At 9:57 AM, the share price was trading at ₹1,140.75, up by 7% on the NSE.

• Aegis Logistics

On Wednesday, Aegis Logistics share price opened at ₹1,027.00, up from its previous close of ₹963.95. At 9:59 AM, the share price of Aegis Logistics was trading at ₹1,006.00, up by 4.36% on the NSE.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.